Vimarsana
Biggest News Aggregation in the World

Data Americas Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Americas Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Americas Inc Today - Breaking & Trending Today

District Court Granted Dismissal Because The Patent Recited A Patent-Ineligible Abstract Idea Of Processing And Transmitting Data - Intellectual Property - Vimarsana News

District Court Granted Dismissal Because The Patent Recited A Patent-Ineligible Abstract Idea Of Processing And Transmitting Data - Intellectual Property

Chief Judge Lynn in the Northern District of Texas recently granted a Rule 12(b)(6) motion to dismiss a complaint alleging patent infringement because the claim-at-issue recites patent-ineligible subject matter...

Source: mondaq.com
District Court Granted Dismissal Because the Patent Recited a Patent-Ineligible Abstract Idea of Processing and Transmitting Data | Akin Gump Strauss Hauer & Feld LLP - Vimarsana News

District Court Granted Dismissal Because the Patent Recited a Patent-Ineligible Abstract Idea of Processing and Transmitting Data | Akin Gump Strauss Hauer & Feld LLP

Chief Judge Lynn in the Northern District of Texas recently granted a Rule 12(b)(6) motion to dismiss a complaint alleging patent infringement because the claim-at-issue recites...

Latest Federal Court Cases - February 2021 #2 | Schwabe, Williamson & Wyatt PC - Vimarsana News

Latest Federal Court Cases - February 2021 #2 | Schwabe, Williamson & Wyatt PC

Amgen Inc. v. Sanofi , Appeal No. 2020-1074 (Fed. Cir. Feb. 11, 2021) In this week’s Case of the Week, the Federal Circuit affirmed a district court’s JMOL ruling that asserted claims of two related pharmaceutical patents were invalid because their shared specification did not enable the full scope of the claims. The patents were directed to synthetic antibodies used in high cholesterol treatments that operate by binding to specified amino acids (or “residues”) of enzyme PCSK9, thereby blocking PCSK9 from binding to LDL cholesterol receptors (“LDLR”) and permitting those receptors...